NUK - logo
E-viri
Recenzirano Odprti dostop
  • The roles of epidermal grow...
    Al Olayan, Ashwaq; Al Hussaini, Hamad; Rahman Jazieh, Abdul

    Journal of infection and public health 5
    Journal Article

    Summary Targeting epidermal growth factor receptor (EGFR) is an important treatment option for non-small cell lung cancer (NSCLC). These targeted therapies have been studied extensively in NSCLC in first line and subsequent lines, including maintenance in empiric fashion or in patients with tumors harboring the EGFR mutations. In this manuscript, we will review in details the evolutions of these targeted therapy in the management of NSCLC.